A large study conducted in Denmark has found no evidence that popular anti-nausea drug Zofran will harm babies if taken during pregnancy.
Around 10 percent of expectant mothers suffer from morning sickness, including nausea and vomiting, which requires prescription medicine.
Zofran is a popular anti-nausea drug that is often recommended for such women though a study recent suggested that it increased the risk of babies being born with cleft palate if taken by pregnant women.
However a Danish Medical Research Council funded study looked at more than 600,000 did not find any evidence that the drug increases the risk of a major birth defect. Around 1,970 women of the 608,385 pregnancies analyzed by the study took Zofran. The study has been published in the New England Journal of Medicine.
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial